Today: 19 May 2026
Browse Category

XETRA:BAYN 10 August 2025 - 6 May 2026

Bayer’s $2.45 Billion Perfuse Deal Puts Eye-Drug Pipeline Back in Focus

Bayer’s $2.45 Billion Perfuse Deal Puts Eye-Drug Pipeline Back in Focus

Bayer agreed to acquire Perfuse Therapeutics for up to $2.45 billion, including $300 million upfront, to gain access to a mid-stage eye-disease drug, PER-001. Eylea, Bayer’s top-selling eye drug, saw 2025 sales fall 5.9% to €3.11 billion amid generic competition. The deal awaits antitrust and shareholder approval. PER-001 is in Phase II trials for glaucoma and diabetic retinopathy.
6 May 2026
··
Pfizer stock gains early as UBS starts coverage; Bayer mRNA lawsuit adds fresh risk

Pfizer stock gains early as UBS starts coverage; Bayer mRNA lawsuit adds fresh risk

Bayer’s Monsanto filed a lawsuit against Pfizer, BioNTech, and Moderna in Delaware federal court, alleging misuse of mRNA technology patents. Pfizer shares rose 0.9% to $25.67 in early trading after UBS began coverage with a Neutral rating and a $25 price target. Investors are watching for Pfizer’s Q4 and full-year 2025 results on February 3.
7 January 2026
····
German Stock Market Outlook Today (9 December 2025): DAX Futures Flat as Fed Cut Bets, Strong Data and M&A Shape the Open

German Stock Market Outlook Today (9 December 2025): DAX Futures Flat as Fed Cut Bets, Strong Data and M&A Shape the Open

Germany’s DAX closed Monday at 24,055, up 0.1%, staying above 24,000. Futures signal a flat or slightly lower open Tuesday. Investors await the U.S. Federal Reserve decision and eye strong German industrial data, though gains were driven by transport and defense orders. Bayer, Rheinmetall, and Deutsche Bank led Monday’s gainers.
9 December 2025
·····
DAX Today After the Bell: German Stock Market Edges Higher as Bayer and Kloeckner Rally – December 8, 2025

DAX Today After the Bell: German Stock Market Edges Higher as Bayer and Kloeckner Rally – December 8, 2025

Germany’s DAX 40 closed at 24,055.69 on Monday, up 0.11%, led by gains in Bayer (+4.70%) and Rheinmetall (+3.63%). Pharmaceuticals and defence stocks outperformed, while real estate lagged as Germany’s 30-year bond yield hit its highest since 2011. The VDAX volatility index fell 2.26% to a one-month low. Broader European markets were mixed, with the STOXX 600 down 0.1%.
8 December 2025
··
Bayer Aktie Soars After U.S. Roundup Breakthrough: Latest News, Analyst Forecasts and 2026 Outlook (4 December 2025)

Bayer Aktie Soars After U.S. Roundup Breakthrough: Latest News, Analyst Forecasts and 2026 Outlook (4 December 2025)

Bayer shares surged over 12% to a near two-year high on December 2, 2025, after the U.S. government urged the Supreme Court to review the company’s Roundup case. The stock briefly touched €35, marking its best trading day in 17 years. Despite the rally, Bayer’s five-year return remains about -40% due to ongoing litigation and restructuring.
4 December 2025
··
German Stock Market Today, December 4, 2025: DAX Climbs on Auto Rally and Fed Cut Hopes but Still Fails to Clear 24,000

German Stock Market Today, December 4, 2025: DAX Climbs on Auto Rally and Fed Cut Hopes but Still Fails to Clear 24,000

The DAX rose 0.8% to 23,877 in late morning trading Thursday, its highest in several sessions but still below the 24,000 mark for a third week. Gains were driven by optimism over possible U.S. rate cuts and a surge in European auto stocks after a bullish sector call. The MDAX, TecDAX, and SDAX also advanced. Mercedes-Benz and Porsche SE led sector gains.
4 December 2025
·····
German Stock Market Today, December 3, 2025: DAX Extends Rebound as Tech & Industrials Rise While PMI and Auto Sector Gloom Weigh

German Stock Market Today, December 3, 2025: DAX Extends Rebound as Tech & Industrials Rise While PMI and Auto Sector Gloom Weigh

Germany’s DAX 40 rose 0.3% to about 23,785 points by late morning Wednesday, extending its rebound after early December losses. Tech and industrial stocks led gains, echoing broader European strength, while fresh PMI data and weak auto sentiment underscored ongoing economic fragility. The MDAX was flat near 29,500. The TecDAX outperformed, up about 0.8%.
3 December 2025
German Stock Market Today, 2 December 2025: DAX Rebounds on Bayer Surge as Inflation Hits 2.2%

German Stock Market Today, 2 December 2025: DAX Rebounds on Bayer Surge as Inflation Hits 2.2%

Germany’s DAX 40 index closed up 0.8% at 23,780.07 on Tuesday, recovering part of Monday’s losses after Bayer surged up to 15% intraday. MDAX mid-caps rose 0.25%, while TecDAX slipped 0.16%. Eurozone November inflation came in at 2.2%, with Germany estimated at 2.6%, reinforcing expectations the ECB will hold rates steady. Market breadth was mixed, with several major stocks trading lower.
2 December 2025
··
Bayer Stock Rockets on U.S. Roundup Breakthrough – Is the 13% Rally the Start of a Trend?

Bayer Stock Rockets on U.S. Roundup Breakthrough – Is the 13% Rally the Start of a Trend?

Bayer shares jumped about 13% to a year high near €34–35 on Xetra after the U.S. Solicitor General backed Bayer’s request for Supreme Court review in the Roundup glyphosate case. The move follows renewed analyst upgrades and fresh pipeline news. Bayer says 132,000 of 197,000 Roundup claims have been resolved or declared ineligible as of October 2025.
2 December 2025
··
German Stock Market Today, 26 November 2025: DAX Extends Rally on Fed Rate‑Cut Bets and Ukraine Peace Hopes

German Stock Market Today, 26 November 2025: DAX Extends Rally on Fed Rate‑Cut Bets and Ukraine Peace Hopes

Germany’s DAX index closed at 23,531.62 on Wednesday, up 0.29%, marking a three-day rebound after hitting five-month lows last week. The MDAX rose 0.21% to 29,078.04, while the TecDAX slipped 0.11% to 3,493.06. Investors weighed weak German growth against expectations of U.S. rate cuts and signs of progress in Russia-Ukraine talks.
26 November 2025
··
Bayer Q3 2025: Adjusted Profit Jumps as Company Books €934m in Litigation Charges—Guidance Intact, Shares Rise

Bayer Q3 2025: Adjusted Profit Jumps as Company Books €934m in Litigation Charges—Guidance Intact, Shares Rise

Bayer reported a 20.8% rise in adjusted third-quarter EBITDA to €1.51 billion, beating analyst forecasts, as revenue reached €9.66 billion. The company booked €934 million in special charges, mostly for U.S. litigation, and raised its full-year special items estimate to up to €4 billion. Bayer kept its profit outlook unchanged. Shares rose as much as 5% intraday.
12 November 2025
···
BayWa Crisis: Cooperatives Take Over as Stock Soars on Rescue Plan

BayWa Crisis: Cooperatives Take Over as Stock Soars on Rescue Plan

BayWa AG’s main cooperative shareholders, BRB and RAI, have taken control and injected over €125 million, launching a rights issue to raise up to €77 million more. The company sold its RWA stake for €176 million and is restructuring after years of debt. BayWa stock rebounded on Oct 28, trading above its theoretical ex-rights price. The firm withdrew its 2025 profit forecast, citing market uncertainty.
28 October 2025
·
Breakthrough Cures, FDA Shake-Ups & Pharma Mega‑Deals: Global Health News Roundup (Aug 9–10, 2025)

Breakthrough Cures, FDA Shake-Ups & Pharma Mega‑Deals: Global Health News Roundup (Aug 9–10, 2025)

China researchers reported a hydrogel “smart” wound dressing that closed 90% of diabetic ulcers in mice within 12 days by delivering microRNA vesicles. The FDA approved Boehringer Ingelheim’s Hernexeos for advanced non-squamous NSCLC, with 75% of treated patients seeing tumors shrink or disappear. U.S. IV saline shortages ended as Baxter’s North Carolina plant resumed production after hurricane damage.
10 August 2025
······

Stock Market Today

  • Lake City Bank Q1 Earnings Outperform Regional Banks Despite Mixed Metrics
    May 19, 2026, 4:27 AM EDT. Lake City Bank (NASDAQ:LKFN) reported a 9.1% year-on-year revenue increase to $70.81 million in Q1, slightly beating analyst estimates. However, the bank missed projections on net interest income and tangible book value per share. The board declared a 4% dividend increase to $0.52 per share, reflecting confidence in loan growth and shareholder returns. Despite Lake City's gains, regional bank stocks overall declined 3% post-earnings amid sector headwinds including fintech competition, deposit outflows, and regulatory pressures. UMB Financial led the sector's Q1 performance. Lake City Bank shares have dipped 2.6% since the results, trading at $58.15 as of early May 2026.

Latest articles

T1 Energy Stock Just Popped 23%. The Filing Behind the Move Is the Story

T1 Energy Stock Just Popped 23%. The Filing Behind the Move Is the Story

19 May 2026
NEW YORK, May 19, 2026, 04:02 EDT T1 Energy Inc. shares jumped 23.46% to close at $7.00 on Monday, then were quoted at $7.39 late in after-hours trade, after a regulatory filing put a 10 million-share position by Situational Awareness LP in public view. The move was a clean single-stock surge, far above the NYSE Composite’s 0.44% gain at Monday’s close. (StockAnalysis) This matters now because the filing landed just as investors are testing T1’s pivot into U.S. solar manufacturing, a capital-heavy plan that has begun to show revenue but still needs money, execution and some policy luck. Tuesday is
HIVE Stock Up 29% While Nasdaq Moves Lower as Traders Eye AI Gigafactory

HIVE Stock Up 29% While Nasdaq Moves Lower as Traders Eye AI Gigafactory

19 May 2026
HIVE Digital Technologies closed at $3.46 on Nasdaq Monday, up 28.6%, and rose to $3.59 after hours following news of a planned 320 MW AI data center near Toronto targeting over 100,000 GPUs. The project is expected to cost C$3.5 billion and open in late 2027. Shares of other crypto miners fell as bitcoin traded near $77,142.
Ameren Holders Approve CEO Compensation, $14 Million Package Not Unanimous

Ameren Holders Approve CEO Compensation, $14 Million Package Not Unanimous

19 May 2026
Ameren shareholders approved executive pay, re-elected the full board, and ratified PwC as auditor. CEO Martin J. Lyons, Jr.’s 2025 compensation rose to $14.06 million, up from $9.73 million the previous year. The “say-on-pay” proposal received over 208 million votes in favor. Ameren shares last traded at $107.38, up $1.02.

Popular

Micron Stock Is Falling Hard As Samsung’s Strike Fight Tests The AI Memory Boom

Micron Stock Is Falling Hard As Samsung’s Strike Fight Tests The AI Memory Boom

18 May 2026
Micron Technology shares dropped 6.4% to $678.30 by early afternoon Monday, reversing an opening surge and hitting a session low as investors pulled back from semiconductor stocks. The decline followed a 6.6% fall Friday and came amid broader chip sector losses, with the Philadelphia semiconductor index down over 2%. Samsung and its union are set to resume talks Tuesday to avert a strike that could disrupt 3% of global memory-chip output.
Go toTop